Send us a text

Biliary Tract Cancers - Cholangiocarcinomas and Gallbladder cancers are often seen as rare and aggressive cancers.

🎙️We tackle Biliary Tract Cancers with the exceptional Professor John Bridgewater.

🎙️Few people are as knowledgable & linked to a cancer as Prof Bridgewater is to cholangiocarcinoma.

🎙️Prof Bridgewater has led practice changing studies in this area and is an internationally renowned expert.

🎙️This group of cancers is more common than you think!

🎙️If you don’t know your gallbladder cancer from your cholangiocarcinoma the check it out wherever you get your podcast!!

Find out more about these cancers at AMMF – The UK's only Cholangiocarcinoma Charity

Also - Check the Transcript!!

Send us a text

Send us a text

We discuss Early Phase Clinical Trials with Dr Natalie Cook from the Christie Early Trials Unit.

We learn how molecular profiling is shaping early phase trials and how future trials may be shaped.

Send us a text

Clinical Trials are the Stepping Stones for the progress we have made over the years in the treatment of cancer.

We talk to Dr Mohini Varughese who is heavily involved in clinical trials in urology and passionate about the delivery of clinical trials across oncology.

We discuss:
🎙️Phase 1,2 &3 trials
💊The benefits for patients
💉The benefits for clinical teams

Send us a text

Join us as we return for Part 2 of our conversation with lead medical advisor to MacMillan - Dr Anthony Cunliffe.

Anthony is also a practising GP with ideas on how we can work better together - starting with how we keep our patients and GP teams up to date with our oncology letters.

We talk about Performance status and why it so important to us in oncology and also how we can make life easier for people to understand our letters without extra work.

The oncology letters from clinics are the lifeblood of information for many patients care so we should try and make them as useful as possible.

Send us a text

How we communicate is so important in all aspects of medicine.

In this special 2 part episode we look at demystifying the Language of Oncology.

Our letters go to GPs and patients and we speak to Dr Anthony Cunliffe who is the medical lead for Macmillan Cancer Support and a practising GP.

If you are GP or acute medic who treats cancer patients or a patient with access to your letters this is a MUST LISTEN.

Also those of us oncologists wanting to make our letters useful for GP teams there is a a LOT to learn!

We try and explain the meaning behind the letters.

He takes us to task about parts of our oncology letters that would be more useful for GPs and patients.

Send us a text

Join us for an episode looking at the role of radiotherapy in cancer treatment.

We discuss the principles of radiotherapy with Dr Grant Stewart who has 20 years experience with radiotherapy treatments.

This is a great episode for anyone wanting to understand the principles of radiotherapy.

IF you are a patient wanting to understand your treatment or a doctor or nurse wanting to know more about radiotherapy please check this out!

Send us a text

We are back again discussing stereotactic ablative body radiotherapy (SABR) with Dr Harshani Green from the Royal Marsden Hospital.

Join us if :

- You want to hear about the evidence from the FASTRACK II trial using renal SABR

- You are a centre thinking about setting up renal SABR

- You want to hear about the challenges of comparing renal SABR with surgery

Will radiotherapy be able to replace cytoreductive nephrectomy in metastatic renal carcinoma?

We discuss this and more (plus Mike produces a Magic Lamp!)

Enjoy